Abstract P2-01-16: Targeted sequencing of plasma-derived vs. urinary cfDNA from patients with triple negative breast cancer - KIVIRID

Abstract P2-01-16: Targeted sequencing of plasma-derived vs. urinary cfDNA from patients with triple negative breast cancer

Authors: Henrike Herzog, Bahriye Aktas, Ivonne Nel

Published: 2022-03-08

DOI: 10.1158/1538-7445.sabcs21-p2-01-16

Source: Full article

Abstract

Abstract